Cargando…

Editorial: Ankylosing Spondylitis and Related Immune-Mediated Disorders

Detalles Bibliográficos
Autores principales:	Fiorillo, Maria Teresa, Haroon, Nigil, Ciccia, Francesco, Breban, Maxime
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557991/ https://www.ncbi.nlm.nih.gov/pubmed/31214188 http://dx.doi.org/10.3389/fimmu.2019.01232

Ejemplares similares

Editorial: Advances in Pathogenesis, Etiology, and Therapies for Ankylosing Spondylitis
por: Chen, Chih-Wei, et al.
Publicado: (2021)

The genetic basis of ankylosing spondylitis: new insights into disease pathogenesis
por: Tsui, Florence WL, et al.
Publicado: (2014)

Intestinal Microbial Metabolites in Ankylosing Spondylitis
por: Scalise, Giuseppe, et al.
Publicado: (2021)

Increasing proportion of female patients with ankylosing spondylitis: a population-based study of trends in the incidence and prevalence of AS
por: Haroon, Nisha N, et al.
Publicado: (2014)

Ankylosing Spondylitis: A Trade Off of HLA-B27, ERAP, and Pathogen Interconnections? Focus on Sardinia
por: Paladini, Fabiana, et al.
Publicado: (2019)

Vesicular traffic-mediated cell-to-cell signaling at the immune synapse in Ankylosing Spondylitis
por: Tavasolian, Fataneh, et al.
Publicado: (2023)

Perspectives on the Genetic Associations of Ankylosing Spondylitis
por: Wordsworth, B. Paul, et al.
Publicado: (2021)

The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study
por: Kuriya, Bindee, et al.
Publicado: (2020)

Therapeutic Targets for Ankylosing Spondylitis – Recent Insights and Future Prospects
por: Perrotta, Fabio Massimo, et al.
Publicado: (2022)

Acute mental health service use is increased in rheumatoid arthritis and ankylosing spondylitis: a population-based cohort study
por: Kuriya, Bindee, et al.
Publicado: (2020)

Role of the microbiome and its metabolites in ankylosing spondylitis
por: Song, Zi-Yi, et al.
Publicado: (2022)

Joint together: The etiology and pathogenesis of ankylosing spondylitis
por: Xiong, Yuehan, et al.
Publicado: (2022)

Peptidomics analysis of plasma in patients with ankylosing spondylitis
por: Zhang, Guo-ning, et al.
Publicado: (2023)

Alterations in the gut virome in patients with ankylosing spondylitis
por: Li, Chen, et al.
Publicado: (2023)

Ankylosing spondylitis and psychiatric disorders in European population: a Mendelian randomization study
por: Zuo, Huifang, et al.
Publicado: (2023)

Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study
por: Wallis, Dinny, et al.
Publicado: (2013)

Genetically predicted ankylosing spondylitis is causally associated with psoriasis
por: Tian, Di, et al.
Publicado: (2023)

Immune cells and their related genes provide a new perspective on the common pathogenesis of ankylosing spondylitis and inflammatory bowel diseases
por: Ding, Yimei, et al.
Publicado: (2023)

Global Proteomic Analyses Reveals Abnormal Immune Regulation in Patients With New Onset Ankylosing Spondylitis
por: Yu, Zongchao, et al.
Publicado: (2022)

GM-CSF Primes Proinflammatory Monocyte Responses in Ankylosing Spondylitis
por: Shi, Hui, et al.
Publicado: (2020)

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
por: McGonagle, Dennis, et al.
Publicado: (2021)

Adalimumab Therapy Restores the Gut Microbiota in Patients With Ankylosing Spondylitis
por: Chen, Zena, et al.
Publicado: (2021)

Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome
por: Yu, Chaojie, et al.
Publicado: (2021)

Emerging Roles of Long Non-Coding RNAs in Ankylosing Spondylitis
por: Sun, Ruifu, et al.
Publicado: (2022)

Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis
por: Wang, Lei, et al.
Publicado: (2023)

Novel regulatory role of non-coding RNAs in ankylosing spondylitis
por: Fang, Yanyan, et al.
Publicado: (2023)

RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis—Novel Targets for Therapy?
por: Vecellio, Matteo, et al.
Publicado: (2019)

From the Genetics of Ankylosing Spondylitis to New Biology and Drug Target Discovery
por: Nancy, Zaarour, et al.
Publicado: (2021)

Serum Metabolomics Signatures Associated With Ankylosing Spondylitis and TNF Inhibitor Therapy
por: Ou, Jiayong, et al.
Publicado: (2021)

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?
por: Baeten, Dominique, et al.
Publicado: (2021)

Platelet-to-Lymphocyte Ratio as an Independent Factor Was Associated With the Severity of Ankylosing Spondylitis
por: Liang, Tuo, et al.
Publicado: (2021)

Ankylosing spondylitis and glaucoma in European population: A Mendelian randomization study
por: Li, Shengjie, et al.
Publicado: (2023)

HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia
por: Paladini, Fabiana, et al.
Publicado: (2009)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Prefoldin 5 and Anti-prefoldin 5 Antibodies as Biomarkers for Uveitis in Ankylosing Spondylitis
por: Kwon, Oh Chan, et al.
Publicado: (2019)

The Early Phases of Ankylosing Spondylitis: Emerging Insights From Clinical and Basic Science
por: Watad, Abdulla, et al.
Publicado: (2018)

A Comprehensive Assessment of Hip Damage in Ankylosing Spondylitis, Especially Early Features
por: Han, Qing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qdi73u70pq064b9151fbuf3o7m